Search results
Democrats ramp up patent fight with drug industry in bid to lower prices
Washington Post· 1 day agoDemocrats have hit on a new tactic in their long battle with drug companies: challenge patents that...
Biologics Makers Have a Patent Protector in US Discovery Statute
Bloomberg Law· 1 day agoThe rapid growth of biologic therapeutics—a class of medicines that are produced in living cells then purified—has led to growth in multi-jurisdictional patent disputes. With ...
3 Stocks With Mouthwatering Dividends You Can Buy Right Now
Motley Fool via Yahoo Finance· 8 hours agoThis year, the company projects its revenue to come in between $6.2 billion and $6.5 billion, which...
2 Dividend Stocks Billionaires Are Buying: Should You?
Motley Fool via Yahoo Finance· 1 day agoThat includes anticoagulant Eliquis, whose patent will expire by the end of the decade. Eliquis is...
Can Seaweed Solve the Beauty Industry's Plastic Problem?
Elle via AOL· 21 hours agoIts patent-pending thermoplastic seaweed resin, appropriately named TPSea, is microplastic-free,...
Jiangsu's Changzhou to create new energy industry ecosystem
China Daily· 4 days agoLarge-scale enterprises in the new energy sector in the city achieved an output value of over 768 billion yuan ($105.99 billion) in 2023, a year-on-year ...
Lucid Group: Bearish Signals in an Unsustainable Business
GuruFocus.com via Yahoo Finance· 2 days agoOnce a super-hyped $90 billion electric vehicle maker, Lucid Group Inc. (NASDAQ:LCID) now faces...
Rihanna Goes Fiery Red in Ferragamo Patent Pumps With Matching Custom Dress to Promote Fenty Beauty...
Footwear News via Yahoo News· 5 days agoA closer look at Rihanna’s shoes. Not only is Rihanna a billionaire entrepreneur and chart-topping...
SANY Leads Industry's Low-Carbon Development with Market Volume of Over US$400 Million
Benzinga· 5 days agoSHANGHAI, June 4, 2024 /PRNewswire/ -- Leading Chinese heavy equipment manufacturer SANY Group ("SANY") has reported that its total revenue of electric products reached 3.146 billion yuan (US$434.78 million) in
Ozempic and Wegovy could soon be challenged by China’s generic competitors
Fast Company Magazine· 2 days agoNovo Nordisk is facing the prospect of intensifying competition in the promising Chinese market...